Wnt inhibitory factor 1 (WIF1) is a marker of osteoblastic differentiation stage and is not silenced by DNA methylation in osteosarcoma
Emma K Baker, Scott Taylor, Ankita Gupte, Alistair M Chalk, Shreya Bhattacharya, Alanna C Green, T John Martin, Dario Strbenac, Mark D Robinson, Louise E Purton, Carl R Walkley
Bone | ELSEVIER SCIENCE INC | Published : 2015
Awarded by Cancer Council of Victoria
Awarded by NHMRC Career Development Award
Awarded by NHMRC
Awarded by NHMRC Senior Research Fellowship
This work was supported by grants from the Cancer Council of Victoria (to C.W., E.B., M.R.; Grant-In-Aid 1047593); NHMRC Career Development Award (to C.W.; 559016); Cure Cancer Australia Foundation Fellowship (to E.B); 5point foundation (to E.B); NHMRC project grant (to L.P.; 1006485); NHMRC Senior Research Fellowship (to L.P.; 1003339); in part by the Victorian State Government Operational Infrastructure Support Program (to St. Vincent's Institute). C.W. is the Philip Desbrow Senior Research Fellow of the Leukaemia Foundation. We thank the SVI Flow Cytometry Core Facility (M Thomson, E Orlowski) for FACS sorting and advice.